Our leadership, which includes our Executive Team and our Board, is responsible for the management of the business and is committed to advancing the HIV response to ensure we leave no person living with HIV behind.

SVP and Head, ViiV Healthcare North America


  • <b>Audrey Abernathy</b> - VP, US Communications and External Affairs

    Audrey Abernathy, VP and Head, US Communications and External Affairs, joined ViiV Healthcare in 2018. Audrey leads a team responsible for US corporate communications and reputation, product communications, internal and digital communications and community support and grant making. Audrey is also a member of the GSK/ViiV US Country Executive Board and the GSK/ViiV US Issues Management team and she is the site lead the new GSK/ViiV Durham work site.

    Audrey has proven experience leading highly effective teams, building and executing results-oriented communications plans that benefit the overall business strategy, and is a trusted strategic counselor experienced in brand PR, therapeutic area market development, reputation building, advocacy relations, crisis and issues management and social/community engagement.

    Prior to joining ViiV Healthcare, Audrey cultivated more than 20 years of corporate and agency experience working across consumer brands and the healthcare industry, notably serving as the Executive Director, Public Affairs for Global Oncology at Bristol Myers Squibb, Director of Communications at Shire Pharmaceutical and Senior Manager, Global and US Vaccines at Pfizer.

    Audrey graduated with a Bachelor of Arts in Communication Studies from The University of North Carolina at Wilmington.

  • <b>Crystal Baker</b> - VP and Head, Legal, North America and Global Medical Legal

    Crystal Baker joined the ViiV Healthcare legal team in 2014. Prior to joining ViiV Healthcare, she supported GSK US and global commercial teams in respiratory and dermatology as well as the global research and development (R&D) organization. In addition to her work supporting the global commercial and global R&D businesses at GSK, Crystal counseled the GSK teams and implemented new transparency initiatives, including the disclosure of US healthcare provider payments and clinical trial data-sharing programs.

    She has worked with the pharmaceutical industry for more than 20 years, including as outside counsel in product liability matters and as a clinical research coordinator prior to attending law school.

    Crystal graduated cum laude from Wake Forest University Undergraduate College and School of Law, where she was selected as a member of the Order of the Coif and Order of the Barristers. She is a member of the North Carolina Bar.

  • <b>Kristin Fink</b> - VP Sales, US

    Kristin Fink joined ViiV Healthcare as VP Sales, US, in 2019. With more than 20 years of pharmaceutical sales experience, she is an award-winning national sales leader who has launched seven global brands in five disease states.

    Kristin has a proven track record of designing and executing go-to-market strategies that power revenue growth and has a keen ability to identify and capitalize on new opportunities, delivering results in record time. She is also a skilled collaborator known for cultivating strong alliances at all levels of an organization to ensure successful product launches and optimize sales force performance across geographies.

    Before joining ViiV Healthcare, Kristin worked with Novartis and Sanofi in various positions, including National VP of Cardiovascular Sales, Head of Cardiovascular Sales, and Associate Vice President, Hematology Marketing, among many more.

    Kristin graduated from Temple University with a Bachelor's Degree in International Business and Finance.

  • <b>Raphael Hebert</b> - Senior Director, US Strategic Operations

    As head of Strategic Operations, Raphael Hebert leads the Insights & Analytics, Training & Capabilities, Patient Access & Affordability and Marketing Operations teams in the US. Prior to this role, he served on the French executive team as Head of Marketing for ViiV Healthcare France after spending time in the field as a US sales director.

    Raphael joined ViiV Healthcare in 2014 from GSK, where he held various roles in the past 18 years, including sales, sales training and marketing across several therapeutic areas, including CV/metabolic, men’s health, neurosciences, respiratory and HIV.

    Raphael graduated from Université Laval with a Bachelor's Degree in Economics and French.

  • <b>Dacia Hibbert</b> - General Manager, Canada

    Dacia Hibbert was appointed to the role of General Manager for ViiV Healthcare Canada in November 2019. With more than 20 years of pharma experience and 16 years in the HIV therapeutic area, Dacia brings a wide range of skills and expertise to her role.

    She began her career in the GSK Laboratory and went on to hold positions of increasing responsibility in Sales, Marketing and Operations. During her marketing tenure, Dacia led the first direct-to-consumer branded campaign to market utilizing real patients in branded and unbranded advertising, highlighting the diversity of experiences of people living with HIV. In her most recent role, Dacia served as Field Vice President in the US Specialty Division, where she led a large sales team in the Northeast.

    Dacia holds a Bachelor's Degree in Biology from Tuskegee University and completed public health course work in international health and infectious disease from Emory University.

  • <b>Debra Kronschnabel</b> - Head, Field Medical and Capability, North America Medical Affairs

    Debra Kronschnabel, Pharm.D., is responsible for the Field Medical Teams in the US and Medical Affairs Capability.

    Prior to joining ViiV Healthcare in 2009, Debra worked at the Children’s Diagnostic and Treatment Center in Ft. Lauderdale, Florida, an HIV epicenter in the South. There she served as HIV clinical and research director with a focus on maternal and pediatric HIV, and led the infectious disease pharmacy internships for Nova Southeastern University. In 2001, she joined GSK as an HIV Medical Science Liaison, taking on roles of increasing leadership in HIV and Respiratory Medical Affairs, and returning to focus solely on HIV as part of the Core Medical Affairs team to launch ViiV in 2009.

    Debra earned a Pharm.D. at Nova Southeastern University and a Bachelor's Degree in Biology, Chemistry and Philosophy from Spring Hill College.

  • <b>Marc Meachem</b> - Head of US External Affairs

    As head of US External Affairs at ViiV Healthcare since 2009, Marc Meachem directs all US external public affairs activities, including ViiV Healthcare's Positive Action Southern Initiative, Positive Action for Women, the accelerate Initiative and the Youth Scholars Program with NMAC.

    Marc has received a number of accolades from the community, including a “Heroes in the Struggle Award” by the Black AIDS Institute, the Angel Award from Gay Men of African Descent, Inc., and a Corporate Leader Award from Iris House.

    With more than two decades of experience in the pharmaceutical industry, Marc has held leadership roles in various therapeutic areas across commercial development, marketing and communications. He earned a Bachelor's Degree in French Language and Literature and a Bachelor's Degree in Economics from the University of Pennsylvania, and an M.B.A. from the Fuqua School of Business at Duke University.

  • <b>Amanda Mott</b> - VP, Market Access

    Amanda Mott joined the ViiV Healthcare team in 2020 as Vice President of US Market Access. Prior to that, she worked at Bristol Myers Squibb serving as head of Organized Customers, where she was responsible for the Celgene portfolio’s supply chain, national and regional accounts, provider systems, Medicare and federal strategy and execution teams. Previously, Amanda led Market Access at Radius Health through the development and commercialization of its first product launch both in the US and globally. Before Radius, Amanda led payer, pricing, government relations, marketing and sales teams at Amgen and AstraZeneca, and she began her career in healthcare as a corporate attorney, counseling clients on Medicare and Medicaid, fraud and abuse, government investigations, contract negotiations and anti-kickback issues.

    In 2014, Amanda was ranked among the healthcare industry’s leading women executives, receiving the Rising Star Award from the Healthcare Businesswomen’s Association for delivering exceptional business results with a passion for patient health and professional development. She is also a Fellow of the International Women’s Forum, which is dedicated to building better global leadership across careers, continents and cultures.

    Amanda is a graduate of the University of Pennsylvania and Marquette University Law School.

  • <b>Anastasia Pucci</b> - HR Business Lead

    Anastasia Pucci joined ViiV Healthcare in 2018 and is responsible for diagnosing and deploying appropriate HR interventions to deliver the business strategy and improve business performance.

    Anastasia was previously the global talent business lead for GSK US Pharma and served as R&D global recruitment account manager and R&D executive search lead in the US. Prior to joining GSK in 2014, she co-founded and led a boutique executive search firm, supporting organizations within the life sciences, technology and finance sectors. She began her career in Canada, recruiting for a global technology consulting firm and helping launch its first US office.

    Anastasia holds a degree in political science from Queen’s University in Canada. She is an American national born in the UK and spent her formative years in South Africa and Canada.

  • <b>Jennifer Vondee</b> - Senior Director North America Compliance

    Jennifer Vondee joined the ViiV Healthcare team as Senior Director North America Compliance in 2021.

    Jennifer is a highly experienced compliance professional with a wealth of knowledge. Prior to joining ViiV Healthcare, she spent more than 14 years at PricewaterhouseCoopers, advising pharmaceutical and biotech companies on healthcare compliance risk management and digital solutions to meet industry-leading practices. Since 2019, Jennifer has been an Editorial Board member for the “Policy & Medicine Compliance Update,” a monthly compliance publication for pharmaceutical biotechnology and device manufacturers.

    Jennifer earned her Master's Degree in Public Health from Emory University Rollins School of Public Health in Atlanta. She also holds a Bachelor's Degree in Computer Science from Rutgers University, New Brunswick.

  • <b>Neil Wilkinson</b> - Head, North America Finance

    Neil Wilkinson has more than 20 years of finance and commercial experience within the manufacturing and pharmaceutical industries and joined ViiV Healthcare as VP & Head of North America Finance in 2018.

    Neil’s experience brings a balanced mix of technical finance and analytical skills, with the ability to translate data and apply insights to all areas of the business, with proven leadership skills across the company.

    Before joining ViiV Healthcare, Neil worked with GSK in various positions, including Head of US Primary Care Finance, Head of Respiratory Franchise Finance, among many more. Neil’s earlier career was with Avery Dennison in the commercial manufacturing space.

    Neil graduated from the University of Huddersfield with an honors-level Bachelor's Degree in Business Administration and is CIMA qualified.

  • <b>Andrew Zolopa</b> - Head, North America Medical Affairs

    As Head of North American Medical Affairs, Andrew Zolopa, MD ensures medical integrity and oversight of ViiV Healthcare initiatives. He is also currently Professor of Medicine in Infectious Diseases, Emeritus, at the Stanford University Medical Center in California.

    Prior to this current role, Andrew served as ViiV Healthcare’s Senior Global Medical Director, providing global medical and scientific expertise and interacting with HIV experts worldwide. Before joining the industry, he was director for 20 years at the Stanford Positive Care Clinic, which he founded in 1994 to provide HIV clinical services for the Stanford Hospital and Clinics. During that time, he also directed the Ira Greene Positive PACE Clinic at the Santa Clara Valley Medical Center for six years. Following a long path of progressive academic appointments at the University of California at San Francisco and Stanford University, Andrew was appointed to Emeritus Professor of Medicine at Stanford University in 2014 and to Honorary Medical Staff Member for Life at Stanford University Hospital and Clinics in 2015.

    Andrew has served nationally and internationally in multiple professional roles, including on advisory boards, as editorial board member or reviewer for medical and HIV specialty journals, and as adviser to the FDA and Institute of Medicine. He has published more than 100 peer-reviewed journal papers, dozens of book chapters and articles, and is frequently invited to speak internationally.